Journal Guide

Immunotherapy offers the scientific community an interdisciplinary forum, providing them with the most recent advances of various aspects of immunotherapeutics to aid navigation of this complex field. Immunotherapy delivers essential information in concise, at-a-glance article formats. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for this vitally important area of research

Bioline International is a pioneer in the provision of open access to peer reviewed bioscience journals published in developing countries. These journals contain timely research on public health, international development, tropical medicine, food and nutritional security and biodiversity that would not otherwise be readily available to researchers in the developed world, or even within the country of publication. Bioline is not a publisher, but an aggregator that provides a free platform for journals who wish to participate in the global open access movement.

The Indian Journal of Surgical Oncology aims to encourage and promote clinical and research activities pertaining to Surgical Oncology. It also aims to bring in the concept of multidisciplinary team approach in management of various cancers.The Journal would publish original article, point of technique, review article, case report, letter to editor, profiles of eminent teachers, surgeons and instititions - a short (up to 500 words) of the Cancer Institutions, departments, and oncologist, who founded new departments.

Infectious Agents and Cancer is ready to receive manuscripts on all aspects of the pathogenic mechanisms of chronic infections and progression to oncogenesis.

Integrative Cancer Therapies (ICT) has been accepted by ISI. An impact factor will be released in the 2008 Journal Citation Reports®. Read the press release here.ICT is the first journal to spearhead and focus on a new and growing movement in cancer treatment. The journal emphasizes scientific understanding of alternative medicine and traditional medicine therapies, and their responsible integration with conventional health care. Integrative care includes therapeutic interventions in diet, lifestyle, exercise, stress care, and nutritional supplements, as well as experimental vaccines, chrono-chemotherapy, and other advanced treatments. Contributors are leading oncologists, researchers, nurses, and health-care professionals.The journal presents scientifically rigorous original research, case studies, current literature reviews, educational roundtables, and commentary on key topics such as: * Treatment strategies * Evaluations of current therapies * Models for integrating complementary and conventional treatment in clinical practice * Interventions from alternative and traditional medicine * Implementing quality-of-life assessment and counseling in the clinical setting * Cancer rehabilitation during and following cancer treatments * Potential interactions of cancer chemotherapy drugs with frequently used dietary supplements * Implementing integrative cancer care strategies into oncology practice * Relevant molecular mechanisms and biology behind integrative approaches * Impact of timing of chemotherapy administration on toxicity, response, and outcome .

International Journal of Breast Cancer is a peer-reviewed, open access journal that publishes original research articles, review articles, and clinical studies related to all aspects of breast cancer.

Aims and Scope TheInternational Journal of Cancer(official journal of the Union for International Cancer Control - UICC) appears 24 times per year.International Journal of Cancerinvites submissions under a broad scope of topics relevant to experimental and clinical cancer research and publishes original research articles. mini reviews. short reports. and letters to the editor. The article categories within the journal are: carcinogenesis. cancer cell biology. cancer genetics. infectious causes of cancer. tumor immunology. early detection and diagnosis. epidemiology. and cancer therapy. 2009 Impact Factor:4.

The International Journal of Clinical Oncology (IJCO) welcomes original research papers on all aspects of clinical oncology that report the results of novel and timely investigations. Reports on clinical trials are encouraged. Experimental studies will also be accepted if they have obvious relevance to clinical oncology. Membership in the Japan Society of Clinical Oncology is not a prerequisite for submission to the journal. Papers are received on the understanding that: their contents have not been published in whole or in part elsewhere; that they are subject to peer review by at least two referees and the Editors, and to editorial revision of the language and contents; and that the Editors are responsible for their acceptance, rejection, and order of publication.

* Biological Abstracts® (Thomson ISI) * BIOSIS Previews® (Thomson ISI) * Biotechnology & Bioengineering Abstracts (CSA/CIG) * Biowizard (Biowizard) * CAB Abstracts® (CABI) * Cambridge Scientific Abstracts (CSA/CIG) * Chemical Abstracts Service/SciFinder (ACS) * CSA Biological Sciences Database (CSA/CIG) * CSA Environmental Sciences & Pollution Management Database (CSA/CIG) * Current Awareness in Biological Sciences (Elsevier) * Current Contents®/Life Sciences (Thomson ISI) * EMBASE/Excerpta Medica (Elsevier) * Google Scholar * Index Copernicus (IC) * Index Medicus/MEDLINE/PubMed (NLM) * Journal Citation Reports/Science Edition (Thomson ISI) * PASCAL Database (INIST/CNRS) * Reference Update (Thomson ISI) * Science Citation Index Expanded™ (Thomson ISI) * Science Citation Index® (Thomson ISI) * SCOPUS (Elsevier) * Web of Science (Thomson ISI).

International Journal of Radiation Oncology • Biology • Physics (IJROBP), known in the field as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both education and health policy as it relates to the field.This journal has a particular interest in original contributions of the following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying cancer and normal tissue radiation response.The Red Journal's sister publication is Practical Radiation Oncology. Click here to see which types of papers these journals typically accept.

International Journal of Surgical Oncology is a peer-reviewed, open access journal that publishes original research articles, review articles, and clinical studies in all areas of surgical oncology.